… syndromes temporally associated with COVID-19 vaccination. Further studies with larger …
to prove or disprove causality association of these syndromes with COVID-19 vaccination. …

… for COVID-19 vaccination was to supply the vulnerable population and prevent unequal
distribution [23, 24]. However, we are now facing vaccine … Vaccine hesitancy refers to delay or …

… to also make COVID-19 a vaccine-preventable disease. The impact of COVID-19 vaccines
on the termination of the pandemic will depend on how many people get vaccinated and how …

… vaccinations and the current data to date on select COVID-19 vaccines including mRNA
vaccines and the adenovirus-vector COVID-19 vaccines, ChAdOx1 nCOV-19 (AstraZeneca) and …

… We requested a report of cases of CVT occurring within 1 month of a COVID-19 vaccination.
Other cerebral events could also be reported. Incidence rates of CVT were calculated by …

… Additionally, once a vaccine becomes available, careful monitoring across age groups and
… The COVID-19 pandemic necessitates close collaboration on a global scale, with a special …

… dose of a COVID-19 vaccine and a post vaccination EEG report … EEG findings post-COVID-19
vaccination. The most frequent … who had received different types of COVID-19 vaccines. …

… for COVID-19 vaccines is likely to far exceed supply initially. More than 10 billion vaccines
… countries get adequate vaccine provision, has been able to secure vaccines for only around …

… may contribute to explain the female predominance in CVST after application of both
COVID-19 vaccines. Given the small sample size and wide confidence intervals, no firm …

… group, 44 (38%) patients died, in comparison to 2 out of 10 (20%) patients in the mRNA
vaccine group and 3 out of 100 (3%) in the pre-COVID-19 group. Mortality among patients with …